Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 03, 2023 10:00 ET | Source: NuProbe USA Inc

NuProbe BDA Technology Enables Highly Sensitive Detection of Low-Level Variants for Oncology Research

Houston, May 03, 2023 (GLOBE NEWSWIRE) -- NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number...
November 07, 2022 14:32 ET | Source: NuProbe USA Inc

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications

Hercules, Calif. and Houston, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and...
June 02, 2022 11:30 ET | Source: NuProbe USA Inc

NuProbe Closes $50M in New Fundraising

Houston, TX, June 02, 2022 (GLOBE NEWSWIRE) -- NuProbe Global, a genomics and molecular diagnostics company, announces the close of its $50M fundraising, co-led by AstraZeneca-CICC Fund, CR-CP Life...
April 19, 2022 10:02 ET | Source: NuProbe USA Inc

NuProbe Published Method for Designing Highly Multiplex PCR Primer Sets

Houston, April 19, 2022 (GLOBE NEWSWIRE) -- NuProbe, a global genomics and molecular diagnostics company, announces its recent publication in Nature Communications describing a massively multiplexed...
April 05, 2022 10:06 ET | Source: NuProbe USA Inc

NuProbe QASeq Technology Enables Simultaneous Ultrasensitive Detection of CNVs and Mutations from FFPE Tissue and cfDNA

Houston, April 05, 2022 (GLOBE NEWSWIRE) -- NuProbe, a global genomics and molecular diagnostics company, announced new published data in Nature Communications describing the use of Quantitative...
January 18, 2022 10:01 ET | Source: NuProbe USA Inc

NuProbe Technology Showcases Quantitative PCR for Simultaneous Enrichment and Identification of Multiple Rare Variants below 0.1% VAF

Houston, Jan. 18, 2022 (GLOBE NEWSWIRE) -- NuProbe, a genomics and molecular diagnostics company developing ultrasensitive assays for precision oncology research, published research today...